1. Engels M, Cross RK, Long MD. Exercise in patients with inflammatory bowel diseases: current perspectives. Clin Exp Gastroenterol. 2017; 11:1–11.
Article
2. Legeret C, Mählmann L, Gerber M, et al. Favorable impact of long-term exercise on disease symptoms in pediatric patients with inflammatory bowel disease. BMC Pediatr. 2019; 19:297.
Article
3. Holik D, Včev A, Milostić-Srb A, et al. The effect of daily physical activity on the activity of inflammatory bowel diseases in therapy-free patients. Acta Clin Croat. 2019; 58:202–212.
Article
4. Mazur-Bialy AI, Bilski J, Wojcik D, et al. Beneficial effect of voluntary exercise on experimental colitis in mice fed a high-fat diet: the role of irisin, adiponectin and proinflammatory biomarkers. Nutrients. 2017; 9:410.
Article
5. Hashash JG, Binion DG. Exercise and inflammatory bowel disease: insights into etiopathogenesis and modification of clinical course. Gastroenterol Clin North Am. 2017; 46:895–905.
6. DeFilippis EM, Tabani S, Warren RU, Christos PJ, Bosworth BP, Scherl EJ. Exercise and self-reported limitations in patients with inflammatory bowel disease. Dig Dis Sci. 2016; 61:215–220.
Article
7. Melinder C, Hiyoshi A, Hussein O, Halfvarson J, Ekbom A, Montgomery S. Physical fitness in adolescence and subsequent inflammatory bowel disease risk. Clin Transl Gastroenterol. 2015; 6:e121.
Article
8. Tew GA, Jones K, Mikocka-Walus A. Physical activity habits, limitations, and predictors in people with inflammatory bowel disease: a large cross-sectional online survey. Inflamm Bowel Dis. 2016; 22:2933–2942.
Article
9. Werkstetter KJ, Ullrich J, Schatz SB, Prell C, Koletzko B, Koletzko S. Lean body mass, physical activity and quality of life in paediatric patients with inflammatory bowel disease and in healthy controls. J Crohns Colitis. 2012; 6:665–673.
Article
10. Chen Y, Noble EG. Is exercise beneficial to the inflammatory bowel diseases? An implication of heat shock proteins. Med Hypotheses. 2009; 72:84–86.
Article
11. Lee SH, Kwon JE, Cho ML. Immunological pathogenesis of inflammatory bowel disease. Intest Res. 2018; 16:26–42.
Article
12. Marchioni Beery RM, Li E, Fishman LN. Impact of pediatric inflammatory bowel disease diagnosis on exercise and sports participation: patient and parent perspectives. World J Gastroenterol. 2019; 25:4493–4501.
Article
13. Bilski J, Brzozowski B, Mazur-Bialy A, Sliwowski Z, Brzozowski T. The role of physical exercise in inflammatory bowel disease. Biomed Res Int. 2014; 2014:429031.
Article
14. Bilski J, Mazur-Bialy AI, Brzozowski B, et al. Moderate exercise training attenuates the severity of experimental rodent colitis: the importance of crosstalk between adipose tissue and skeletal muscles. Mediat Inflamm. 2015; 2015:605071.
Article
15. Greenley RN, Naftaly JP, Walker RJ, Kappelman MD, Martin CF, Schneider KL. Sports participation in youth with inflammatory bowel diseases: the role of disease activity and subjective physical health symptoms. Inflamm Bowel Dis. 2018; 24:247–253.
Article
16. Stokes T, Hector AJ, Morton RW, McGlory C, Phillips SM. Recent perspectives regarding the role of dietary protein for the promotion of muscle hypertrophy with resistance exercise training. Nutrients. 2018; 10:180.
Article
17. Schoenfeld BJ. The mechanisms of muscle hypertrophy and their application to resistance training. J Strength Cond Res. 2010; 24:2857–2872.
Article
18. Elia J, Kane S. Adult inflammatory bowel disease, physical rehabilitation, and structured exercise. Inflamm Bowel Dis. 2018; 24:2543–2549.
Article
19. Przybyla B, Gurley C, Harvey JF, et al. Aging alters macrophage properties in human skeletal muscle both at rest and in response to acute resistance exercise. Exp Gerontol. 2006; 41:320–327.
Article
20. Vasconcelos ES. Inflammatory response induced by resistance exercise. MOJ Immunol. 2018; 6:110–113.
Article
21. Coffey VG, Hawley JA. The molecular bases of training adaptation. Sports Med. 2007; 37:737–763.
Article
22. Wiroth JB, Filippi J, Schneider SM, et al. Muscle performance in patients with Crohn’s disease in clinical remission. Inflamm Bowel Dis. 2005; 11:296–303.
Article
23. Cabalzar AL, Oliveira DJ, Reboredo MD, Lucca FA, Chebli JM, Malaguti C. Muscle function and quality of life in the Crohn’s disease. Fisioter Mov. 2017; 30:337–345.
Article
24. Robinson RJ, Krzywicki T, Almond L, et al. Effect of a low-impact exercise program on bone mineral density in Crohn’s disease: a randomized controlled trial. Gastroenterology. 1998; 115:36–41.
Article
25. Candow D, Rizzi A, Chillibeck P, Worobetz L. Effect of resistance training on Crohn’s disease. Can J Appl Physiol. 2002; 27:S7–S8.
26. Pérez CA. Prescription of physical exercise in Crohn’s disease. J Crohns Colitis. 2009; 3:225–231.
Article
27. De Souza Tajiri GJ, de Castro CL, Zaltman C. Progressive resistance training improves muscle strength in women with inflammatory bowel disease and quadriceps weakness. J Crohns Colitis. 2014; 8:1749–1750.
Article
28. Cronin O, Barton W, Moran C, et al. Moderate-intensity aerobic and resistance exercise is safe and favorably influences body composition in patients with quiescent inflammatory bowel disease: a randomized controlled cross-over trial. BMC Gastroenterol. 2019; 19:29.
Article
29. Pourrahim Ghouroghchi A, Pahlevani M. Effects of maximal and sub-maximal resistance exercise on muscle damage, inflammation, intrinsic antioxidant in non-athlete men. Koomesh. 2020; 22:351–358.
Article
30. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009; 361:2066–2078.
Article
31. Lee JH, Jun HS. Role of myokines in regulating skeletal muscle mass and function. Front Physiol. 2019; 10:42.
Article
32. Carrillo JLM, Del Campo JOM, Coronado OG, Gutiérrez PTV, Cordero JFC, Juárez JV. Adipose tissue and inflammation. In : Szablewski L, editor. Adipose tissue. London: IntechOpen;2018.
https://doi.org/10.5772/intechopen.74227.
Article
33. Raines C, Frosig T, Escobar KA, Cotter JA, Schick EE. Acute resistance exercise at varying volume loads does not enhance plasma interleukin-6. Int J Kinesiol Sports Sci. 2020; 8:37–42.
Article
34. Hirose L, Nosaka K, Newton M, et al. Changes in inflammatory mediators following eccentric exercise of the elbow flexors. Exerc Immunol Rev. 2004; 10:75–90.
35. Neurath MF, Finotto S. IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer. Cytokine Growth Factor Rev. 2011; 22:83–89.
Article
36. Atreya R, Neurath MF. Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer. Clin Rev Allergy Immunol. 2005; 28:187–196.
Article
37. Subramaniam K, Fallon K, Ruut T, et al. Infliximab reverses inflammatory muscle wasting (sarcopenia) in Crohn’s disease. Aliment Pharmacol Ther. 2015; 41:419–428.
Article
38. Barbieri M, Ferrucci L, Ragno E, et al. Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons. Am J Physiol Endocrinol Metab. 2003; 284:E481–E487.
39. Valentini L, Schaper L, Buning C, et al. Malnutrition and impaired muscle strength in patients with Crohn’s disease and ulcerative colitis in remission. Nutrition. 2008; 24:694–702.
Article